Tag Archives: SNTA

Quick Highlights of Most Active Stocks: Sodastream, Synta, Zynga, Cracker Barrel, Affymax, Hospira, Johnson

Posted on June 4, 2013 by Thomas Vedder

Sodastream International Ltd (NASDAQ:SODA) is still being disrespected in spite of stock lifting strongly current year to retrace much of mid-2011’s tumble, Barclays reports, boosting its EPS views for the firm through 2014 and hiking its price target to $100 …

Posted in Latest Headlines, Services | Tagged AFFY, Affymax, CBRL, Cracker Barrel, Hospira, HSP, JNJ, Johnson, NASDAQ:AFFY, NASDAQ:CBRL, NASDAQ:SNTA, NASDAQ:SODA, NASDAQ:ZNGA, NYSE:HSP, NYSE:JNJ, SNTA, SODA, Sodastream, Synta, ZNGA, Zynga | Comments Off

Healthcare Sector Quick Roundup: Quest Diagnostics (NYSE:DGX), Synta Pharmaceuticals (NASDAQ:SNTA) – DGX, SNTA, PFE, CHDX, FLML, OREX

Posted on March 15, 2013 by Thomas Vedder

Thursday’s trading session data confirmed that healthcare sector finished positively with +0.34% change. Chindex International, Inc (NASDAQ:CHDX) and Flamel Technologies SA (ADR) (NASDAQ:FLML) were major percentage gainers in this sector while key percentage decliner was Orexigen Therapeutics, Inc (NASDAQ:OREX).

Quest …

Posted in Healthcare, Latest Headlines | Tagged CHDX, Chindex International, DGX, Flamel Technologies, FLML, NASDAQ:CHDX, NASDAQ:FLML, NASDAQ:OREX, NASDAQ:SNTA, NYSE:DGX, NYSE:PFE, OREX, Orexigen Therapeutics, PFE, Pfizer, Quest Diagnostics, SNTA, Synta Pharmaceuticals | Comments Off

Healthcare Sector Recap; Boston Scientific (BSX) Plans to Lower 1000 Jobs while Eli Lilly (LLY) Profit Tumble – BSX, LLY, PFE, KERX, RPRX, SNTA

Posted on January 30, 2013 by Geoff Noir

Last trading session data confirmed that healthcare sector reacted positively with +0.99% change. Keryx Biopharmaceuticals (NASDAQ:KERX) and Repros Therapeutics Inc (NASDAQ:RPRX) were major percentage gainers in this sector while key decliner was Synta Pharmaceuticals Corp (NASDAQ:SNTA).

The Natick, Massachusetts- based …

Posted in Healthcare, Latest Headlines | Tagged Boston Scientific, BSX, Eli Lilly, KERX, Keryx Biopharmaceuticals, LLY, NASDAQ:KERX, NASDAQ:RPRX, NASDAQ:SNTA, NYSE:BSX, NYSE:LLY, NYSE:PFE, PFE, Pfizer, Repros Therapeutics, RPRX, SNTA, Synta | Comments Off

Friday’s big time losers (EK, PSMT, SNTA)

Posted on January 6, 2012 by Josie Middleton

In this report: PriceSmart (NASDAQ:PSMT), Synta Pharmaceuticals (NASDAQ:SNTA) and Eastman Kodak (NYSE:EK).

PriceSmart (NASDAQ:PSMT) shares tanked by more than 13 percent today after the company reported a 6 percent drop in first quarter net income as increased expenses offset higher …

Posted in Latest Headlines, Technology | Tagged bankruptcy, Chapter 11, common stock, company, Eastman Kodak, EK, expenses, NASDAQ, NASDAQ:PSMT, NASDAQ:SNTA, net income, NYSE, NYSE:EK, offering, portfolio, PriceSmart, PSMT, reported, revenue, rumor, shares, SNTA, speculation, Synta Pharmaceuticals, wall street journal, WSJ | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.